P/16/2011

Key facts

Invented name
Nevanac
Active substance
nepafenac
Therapeutic area
Ophthalmology
Decision number
P/16/2011
PIP number
P/16/2011
Pharmaceutical form(s)
  • Eye drops
  • suspension
Condition(s) / indication(s)
Prevention of post operative pain and inflammation associated with cataract surgery Treatment of post operative pain and inflammation associated with cataract surgery
Route(s) of administration
Ocular use
Contact for public enquiries
Alcon Laboratories (UK) Ltd.
Doug.MacHatton@AlconLabs.com
United States
Phone: +1 8175518974
Fax: +1 8176154607
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating